HIMACS (4299) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
20 Jul, 2026Executive summary
Net sales rose 2.9% year-over-year to ¥4,454 million for the quarter ended June 30, 2025.
Operating profit declined 22.0% year-over-year to ¥235 million, with ordinary profit down 21.7% to ¥237 million.
Profit attributable to owners of parent fell 22.4% year-over-year to ¥161 million.
Comprehensive income decreased 25.4% year-over-year to ¥151 million.
Financial highlights
Gross profit for the quarter was ¥881 million, down from ¥915 million year-over-year.
Basic earnings per share dropped to ¥13.85 from ¥17.90 year-over-year.
Equity-to-asset ratio improved to 82.8% as of June 30, 2025, up from 81.6% at March 31, 2025.
Net assets per share decreased to ¥1,006.34 from ¥1,016.35 at the previous fiscal year-end.
Outlook and guidance
Full-year net sales forecasted at ¥20,000 million, up 10.7% year-over-year.
Operating profit projected at ¥1,820 million, a 0.7% increase year-over-year.
Profit attributable to owners of parent expected to decline 3.7% to ¥1,245 million.
Basic earnings per share for the year forecasted at ¥107.20.
Latest events from HIMACS
- Stable sales and profit growth with positive full-year outlook and robust equity position.4299
Q1 202520 Jul 2026 - Profits and sales rose year-over-year, with strong outlook and higher dividend forecast.4299
Q2 202520 Jul 2026 - Sales and profits rose, with FY2026 sales growth forecast but lower net profit expected.4299
Q4 202520 Jul 2026 - Profits and sales rose year-over-year, with a higher full-year outlook and dividend forecast.4299
Q3 202520 Jul 2026 - Sales rose modestly, but profits declined; full-year outlook expects higher sales and stable margins.4299
Q2 202620 Jul 2026 - Revenue grew slightly, but profits and cash reserves declined due to higher expenses and share buybacks.4299
Q3 202620 Jul 2026 - Sales rose modestly, but profits fell and next year's earnings are forecast to decline further.4299
Q4 202620 Jul 2026